Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes
Condition:   Type 1 Diabetes Interventions:   Drug: Empagliflozin;   Drug: Placebo Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Diabetes Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars
Conditions:   Scars;   Insulin Interventions:   Other: Microneedling with topical application of regular insulin;   Other: Microneedling with topical application of saline Sponsor:   Alexandria University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes
Condition:   Type 1 Diabetes Interventions:   Drug: Empagliflozin;   Drug: Placebo Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Diabetes Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars
Conditions:   Scars;   Insulin Interventions:   Other: Microneedling with topical application of regular insulin;   Other: Microneedling with topical application of saline Sponsor:   Alexandria University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes
Condition:   Type 1 Diabetes Interventions:   Drug: Empagliflozin;   Drug: Placebo Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Diabetes Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars
Conditions:   Scars;   Insulin Interventions:   Other: Microneedling with topical application of regular insulin;   Other: Microneedling with topical application of saline Sponsor:   Alexandria University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes
Condition:   Type 1 Diabetes Interventions:   Drug: Empagliflozin;   Drug: Placebo Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Diabetes Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars
Conditions:   Scars;   Insulin Interventions:   Other: Microneedling with topical application of regular insulin;   Other: Microneedling with topical application of saline Sponsor:   Alexandria University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes
Condition:   Type 1 Diabetes Interventions:   Drug: Empagliflozin;   Drug: Placebo Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Diabetes Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

Insulin Resistance in Egyptian Patients With Multiple Sclerosis
Conditions:   Multiple Sclerosis;   Insulin Resistance Intervention:   Other: treatment of insulin resistance with appropriate modality according to each patient Sponsor:   Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials

Clinical Trial To Determine The Efficacy And Safety Of Insulin Eye Drops In Dry Eye In Patients With Topical Hypotensors
Conditions:   Dry Eye;   Glaucoma Interventions:   Drug: Insulin;   Drug: Artificial tear Sponsor:   Barbara Burgos Blasco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials